“What if the strongest clue for better brain disease’s drug targets are already inside the human brain — and a new technology can finally read it?”

The Next-Generation of
drug target discovery is here

De-risking chemical and biological entity decision for R&D teams across pharma and biotech

We exist to pioneer the next chapter of drug target discovery in neurology supporting the next generation of disease modyfing therapies for diseases like Alzheimer’s and Multiple sclerosis.

Our pipeline identifies real disease signals from gene expression methods, determines which cells are responding to pathology, and links potential druggable targets to these systems. Learn More